Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Arq. bras. cardiol ; 105(2): 151-159, Aug. 2015. tab, ilus
Article in English | LILACS | ID: lil-757998

ABSTRACT

AbstractBackground:Organ injury occurs not only during periods of ischemia but also during reperfusion. It is known that ischemia reperfusion (IR) causes both remote organ and local injuries.Objective:This study evaluated the effects of tramadol on the heart as a remote organ after acute hindlimb IR.Methods:Thirty healthy mature male Wistar rats were allocated randomly into three groups: Group I (sham), Group II (IR), and Group III (IR + tramadol). Ischemia was induced in anesthetized rats by left femoral artery clamping for 3 h, followed by 3 h of reperfusion. Tramadol (20 mg/kg, intravenous) was administered immediately prior to reperfusion. At the end of the reperfusion, animals were euthanized, and hearts were harvested for histological and biochemical examination.Results:The levels of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were higher in Groups I and III than those in Group II (p < 0.05). In comparison with other groups, tissue malondialdehyde (MDA) levels in Group II were significantly increased (p < 0.05), and this increase was prevented by tramadol. Histopathological changes, including microscopic bleeding, edema, neutrophil infiltration, and necrosis, were scored. The total injuryscore in Group III was significantly decreased (p < 0.05) compared with Group II.Conclusion:From the histological and biochemical perspectives, treatment with tramadol alleviated the myocardial injuries induced by skeletal muscle IR in this experimental model.


ResumoFundamento:Lesões a órgãos ocorrem não apenas durante períodos de isquemia, mas paradoxalmente, também durante a reperfusão. Sabe-se que a reperfusão pós-isquêmica (RPI) causa lesões tanto remotas quanto locais no órgão afetado.Objetivo:Este estudo avaliou os efeitos do tramadol no coração como órgão remoto, após RPI aguda dos membros posteriores.Métodos:Trinta ratos Wistar, machos, adultos e saudáveis, foram distribuídos aleatoriamente em três grupos: Grupo I (controle), Grupo II (RPI) e Grupo III (RPI + tramadol). Isquemia foi induzida em ratos anestesiados através do pinçamento da artéria femoral esquerda por 3 horas, seguidas de 3 horas de reperfusão. Tramadol foi administrado (20 mg/kg, IV) imediatamente antes da reperfusão. Ao final da reperfusão, os animais foram sacrificados e seus corações coletados para exames histológicos e bioquímicos.Resultados:Os níveis de superóxido-dismutase (SOD), catalase (CAT) e glutationa-peroxidase (GPx) foram maiores nos grupos I e III que no grupo II (p < 0.05). Em comparação aos outros grupos, os níveis tissulares de malondialdeído (MDA) estavam significativamente mais elevados no grupo II (p < 0.05), o que foi evitado pelo uso de tramadol. Foram pontuadas as alterações histopatológicas, incluindo micro-hemorragia, edema, infiltração por neutrófilos e necrose. A pontuação total das lesões do grupo III foi significativamente menor (p < 0.05) em comparação ao grupo II.Conclusão:Do ponto de vista histológico e bioquímico, o tratamento com tramadol diminuiu as lesões miocárdicas induzidas pela RPI da musculatura esquelética neste modelo experimental.


Subject(s)
Animals , Male , Ischemia/prevention & control , Myocardial Reperfusion Injury/prevention & control , Narcotics/pharmacology , Tramadol/pharmacology , Femoral Artery , Heart/drug effects , Hindlimb/blood supply , Ischemia/complications , Ischemia/drug therapy , Malondialdehyde/analysis , Myocardial Reperfusion Injury/drug therapy , Myocardial Reperfusion Injury/etiology , Myocardial Reperfusion Injury/pathology , Narcotics/therapeutic use , Oxidoreductases/analysis , Random Allocation , Rats, Wistar , Reproducibility of Results , Time Factors , Treatment Outcome , Tramadol/therapeutic use
2.
J. bras. nefrol ; 36(4): 512-518, Oct-Dec/2014. tab
Article in English | LILACS | ID: lil-731151

ABSTRACT

Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. .


Introdução: A tuberculose é uma infecção oportunista comum em pacientes transplantados renais. Objetivo: Oferecer uma descrição clínica e laboratorial de pacientes transplantados com diagnóstico de tuberculose e sua resposta ao tratamento durante o período entre 2005 e 2013 no Hospital Pablo Tobón Uribe. Métodos: Estudo retrospectivo descritivo. Resultados: Em 641 transplantes renais, a tuberculose foi confirmada em 12 pacientes. Destes, 25% tinham histórico de rejeição aguda e 50% apresentaram níveis de creatinina superiores a 1,5 mg/dl antes da infecção. A patologia geralmente se apresentava como pulmonar (50%) e disseminada (33,3%). A primeira fase do tratamento consistiu de três meses de HZRE (isoniazida, pirazinamida, rifampicina e etambutol) em 75% dos casos e HZME (isoniazida, pirazinamida, moxifloxacina e etambutol) em 25% dos pacientes. Durante a segunda fase do tratamento, 75% dos pacientes receberam isoniazida e rifampicina e 25% isoniazida e etambutol. A duração do tratamento variou entre seis e 18 meses. Em 41,7% dos pacientes, hepatotoxicidade foi associada ao início do tratamento da tuberculose. Durante o seguimento de um ano a função renal manteve-se estável e a taxa de mortalidade foi de 16,7%. Conclusão: A tuberculose foi responsável por diversos sintomas inespecíficos na população de transplantados renais estudada. Tuberculose pulmonar e disseminada foram as formas mais frequentes de acometimento e necessitaram de tratamento prolongado. Medicamentos contra a tuberculose apresentaram alta toxicidade e mortalidade. Esta infecção deve ser considerada quando o paciente apresenta síndrome febril de origem desconhecida, especialmente durante o primeiro ano após o transplante renal. .


Subject(s)
Animals , Female , Male , Mice , Locus Coeruleus/drug effects , Narcotics/pharmacology , Neural Inhibition/drug effects , Neurons/drug effects , Potassium Channels/metabolism , Barium/pharmacology , Calcium/metabolism , Enkephalin, Methionine/pharmacology , G Protein-Coupled Inwardly-Rectifying Potassium Channels , GTP-Binding Proteins/metabolism , Heterozygote , Homozygote , Ion Channel Gating/drug effects , Ion Channel Gating/physiology , Locus Coeruleus/cytology , Locus Coeruleus/physiology , Mice, Knockout , Membrane Potentials/drug effects , Membrane Potentials/physiology , Neural Inhibition/physiology , Neurons/physiology , Patch-Clamp Techniques , Protein Subunits , Potassium Channel Blockers/pharmacology , Potassium Channels, Inwardly Rectifying/antagonists & inhibitors , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels, Inwardly Rectifying/metabolism , Potassium Channels/deficiency , Potassium Channels/genetics
3.
Clinics ; 66(1): 151-157, 2011. ilus, tab
Article in English | LILACS | ID: lil-578612

ABSTRACT

OBJECTIVES: To investigate the effect of opioid receptor blockade on the myocardial protection conferred by chronic exercise and to compare exercise training with different strategies of myocardial protection (opioid infusion and brief periods of ischemia-reperfusion) preceding irreversible left anterior descending coronary ligation. INTRODUCTION: The acute cardioprotective effects of exercise training are at least partly mediated through opioid receptor-dependent mechanisms in ischemia-reperfusion models. METHODS: Male Wistar rats (n = 76) were randomly assigned to 7 groups: (1) control; (2) exercise training; (3) morphine; (4) intermittent ischemia-reperfusion (three alternating periods of left anterior descending coronary occlusion and reperfusion); (5) exercise training+morphine; (6) naloxone (a non-selective opioid receptor blocker) plus morphine; (7) naloxone before each exercise-training session. Myocardial infarction was established in all groups by left anterior descending coronary ligation. Exercise training was performed on a treadmill for 60 minutes, 5 times/week, for 12 weeks, at 60 percent peak oxygen (peak VO2). Infarct size was histologically evaluated. RESULTS: Exercise training significantly increased exercise capacity and ΔVO2 (VO2 peak - VO2 rest) (p<0.01 vs. sedentary groups). Compared with control, all treatment groups except morphine plus naloxone and exercise training plus naloxone showed a smaller infarcted area (p<0.05). No additional decrease in infarct size occurred in the exercise training plus morphine group. No difference in myocardial capillary density (p = 0.88) was observed in any group. CONCLUSIONS: Exercise training, morphine, exercise training plus morphine and ischemia-reperfusion groups had a smaller infarcted area than the control group. The effect of chronic exercise training in decreasing infarct size seems to occur, at least in part, through the opioid receptor stimulus and not by increasing ...


Subject(s)
Animals , Male , Rats , Myocardial Infarction/prevention & control , Physical Conditioning, Animal/physiology , Receptors, Opioid/antagonists & inhibitors , Case-Control Studies , Cardiotonic Agents/pharmacology , Morphine/pharmacology , Myocardial Infarction/pathology , Myocardial Reperfusion Injury/prevention & control , Narcotics/pharmacology , Oxygen Consumption/physiology , Physical Exertion/physiology , Random Allocation , Rats, Wistar , Time Factors
4.
Journal of Korean Medical Science ; : 290-296, 2011.
Article in English | WPRIM | ID: wpr-123276

ABSTRACT

The purpose of this study is to determine 1) whether morphine postconditiong (MPostC) can attenuate the intercellular adhesion molecules-1 (ICAM-1) expression after reoxygenation injury and 2) the subtype(s) of the opioid receptors (ORs) that are involved with MPostC. Human umbilical vein endothelial cells (HUVECs) were subjected to 6 hr anoxia followed by 12 hr reoxygenation. Three morphine concentrations (0.3, 3, 30 microM) were used to evaluate the protective effect of MPostC. We also investigated blockading the OR subtypes' effects on MPostC by using three antagonists (a micro-OR antagonist naloxone, a kappa-OR antagonist nor-binaltorphimine, and a delta-OR antagonist naltrindole) and the inhibitor of protein kinase C (PKC) chelerythrine. As results, the ICAM-1 expression was significantly reduced in the MPostC (3, 30 microM) groups compared to the control group at 1, 6, 9, and 12 hours reoxygenation time. As a consequence, neutrophil adhesion was also decreased after MPostC. These effects were abolished by coadministering chelerythrine, nor-binaltorphimine or naltrindole, but not with naloxone. In conclusion, it is assumed that MPostC could attenuate the expression of ICAM-1 on endothelial cells during reoxygenation via the kappa and delta-OR (opioid receptor)-specific pathway, and this also involves a PKC-dependent pathway.


Subject(s)
Animals , Humans , Benzophenanthridines/pharmacology , Endothelial Cells/cytology , Endothelium, Vascular/cytology , Intercellular Adhesion Molecule-1/genetics , Morphine/pharmacology , Naloxone/pharmacology , Naltrexone/analogs & derivatives , Narcotic Antagonists/pharmacology , Narcotics/pharmacology , Protein Isoforms/metabolism , Protein Kinase C/antagonists & inhibitors , Receptors, Opioid/metabolism , Reperfusion Injury/metabolism , Signal Transduction/physiology , Umbilical Veins/cytology
5.
Braz. j. med. biol. res ; 43(9): 899-905, Sept. 2010. ilus
Article in English | LILACS | ID: lil-556854

ABSTRACT

It is well established that morphine inhibits maternal behaviors. Previous studies by our group have shown activation of the rostrolateral periaqueductal gray (rlPAG) upon inhibition-intended subcutaneous injections of morphine. In this context, we demonstrated that a single naloxone infusion into the rlPAG, following this opioid-induced inhibition, reactivated maternal behaviors. Since these data were obtained by using peripheral morphine injections, the present study was designed to test whether morphine injected directly into the rlPAG would affect maternal behaviors. Our hypothesis that morphine acting through the rlPAG would disrupt maternal behaviors was confirmed with a local infusion of morphine. The mothers showed shorter latency for locomotor behavior to explore the home cage (P = 0.049). Inhibition was especially evident regarding retrieving (P = 0.002), nest building (P = 0.05) and full maternal behavior (P = 0.023). These results support the view that opioidergic transmission plays a behaviorally meaningful inhibitory role in the rostrolateral PAG.


Subject(s)
Animals , Female , Male , Rats , Maternal Behavior/drug effects , Morphine/pharmacology , Narcotics/pharmacology , Periaqueductal Gray/drug effects , Animals, Newborn , Maternal Behavior/physiology , Periaqueductal Gray/physiology , Rats, Wistar , Reaction Time/drug effects
6.
Article in English | IMSEAR | ID: sea-110561

ABSTRACT

BACKGROUND: Presently, in vitro and in vivo screening of anti-tubercular drugs is a time-consuming exercise. Therefore, it is important to develop faster methods. MATERIAL AND METHODS: Towards this end, conventional plating and radiometric BACTEC methods of anti-tubercular screening were compared to determine the efficacy of anti-tubercular drugs (isoniazid and rifampicin) and morphine in Mycobacterium tuberculosis H37Rv-infected mice and macrophages. RESULTS: A linear correlation (R2 = 0.95) was observed between number of colony forming units (CFUs) and growth index (GI) values. BACTEC method was found to be faster and sensitive as compared to plating method. Further, BACTEC method, being a closed system, appeared to be less susceptible to microbial contamination and poses less biohazard. CONCLUSION: We conclude that BACTEC method can be employed for easy, precise, and rapid screening of anti-tubercular compounds and morphine in mice and macrophage models.


Subject(s)
Animals , Antibiotics, Antitubercular/pharmacology , Bacteriological Techniques , Cells, Cultured , Colony Count, Microbial , Female , Humans , Isoniazid/pharmacology , Lung/microbiology , Macrophages/drug effects , Male , Mice , Microbial Sensitivity Tests/methods , Morphine/pharmacology , Mycobacterium tuberculosis/drug effects , Narcotics/pharmacology , Radiometry , Rifampin/pharmacology , Spleen/microbiology
8.
Heart Views. 2000; 1 (7): 272-276
in English | IMEMR | ID: emr-53877

ABSTRACT

Diagnostic procedures make up a major portion of the practice of pediatric cardiology. Patient cooperation, often for extended periods, is of utmost importance for successful complication of many pediatric cardiac diagnostic procedures particularly those involving infants and preschool-age children. This requires the use of sedation. Invasive procedures such as cardiac catheterization and transesophageal echocardiography may cause significant discomfort, necessitating the use of additional analgesic and amnesic agents. Multiple drugs or repeated dose may be required during lengthy procedures. Ensuring patient safety by appropriate cardiorespiratory monitoring is mandatory. This review focuses on the pharmacologic agents used in pediatric cardiac catheterization. The pharmacology, indications for usage, and the risks and benefits of commonly used agents are addressed


Subject(s)
Humans , Pediatrics , Conscious Sedation , Meperidine/pharmacology , Promethazine/pharmacology , Chlorpromazine/pharmacology , Propofol/pharmacology , Midazolam/pharmacology , Ketamine/pharmacology , Narcotics/pharmacology , Anesthesia, General
9.
Rev. argent. anestesiol ; 57(4): 234-42, jul.-ago. 1999.
Article in Spanish | LILACS | ID: lil-258630

ABSTRACT

En este artículo se traza una corta historia sobre el opio y sus alcaloides. Se ha examinado el fascinante tema de los péptidos endógenos, morfínicos y encefalinas, y de los receptores específicos para ellos, sus localizaciones y efectos analgésicos o no. Finalmente se ha hecho hincapié en la utilización clínica de la morfina y los morfínicos sintéticos existentes en el mercado, sus efectos analgésicos, el estrés anestésico quirúrgico y sus interacciones con otras drogas coadyuvantes: hipnóticas, anestésicas y también aquéllas con efectos cardiológicos como los bloqueantes beta y los cálcicos. Se describen las técnicas más apropiadas para aprovechar sus propiedades de acuerdo a su farmacodinamia y farmacocinesia. El autor expresa algunas opiniones derivadas de su experiencia en el uso de los opioides en altas dosis.


Subject(s)
Humans , Narcotics/administration & dosage , Narcotics/pharmacokinetics , Narcotics/pharmacology , Narcotics/history , Narcotics/therapeutic use , Alfentanil , Ambulatory Surgical Procedures , Anesthesia, Intravenous , Drug Interactions , Fentanyl , Morphine , Stress, Physiological , Sufentanil , Thoracic Surgery
10.
Rev. méd. Chile ; 127(3): 341-8, mar. 1999.
Article in Spanish | LILACS | ID: lil-243801

ABSTRACT

The immune response is partly regulated by the nervous system, that involves endogenous opioids, stimulating or depressing immune responses. Opioids modulate immune response by indirect and direct mechanisms. Indirect modulation occurs when the activation of opioid receptors within the nervous system modifies the activity of neuroendocrine axes or neurotransmission pathways. Direct modulation results from the effects of opioids on immune system cells. This requires the expression of membrane opioid receptors in these cells. Immunomodulating effects of morphine would be a result of the integration of indirect and direct effects. In animal models, morphine transiently depresses cellular and humoral immunity. In humans, morphine has similar effects; however, the real impact of morphine administration on the immune response in clinical situations in not yet known


Subject(s)
Humans , Immune System/drug effects , Narcotics/pharmacology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Morphine/pharmacology , Adjuvants, Immunologic/pharmacology , Killer Cells, Natural , Killer Cells, Natural/immunology , Narcotics/immunology , Immune Tolerance
11.
Braz. j. med. biol. res ; 31(6): 805-10, jun. 1998. tab, graf
Article in English | LILACS | ID: lil-210970

ABSTRACT

We have previously demonstrated that acute third ventricle injections of both lead and cadmium prevent the dipsogenic response elicited by dehydration or by central injections of dipsogenic agents such as angiotensin II, carbachol and isoproterenol in rats. We have also shown that the antidipsogenic action of cadmium may be due, at least in part, to activation of thirst-inhibitory central serotonergic pathways. In the present paper we show that in Wistar male rats the antidipsogenic effect of both lead acetate (3.0 nmol/rat) and cadmium chloride (3.0 nmol/rat) may be partially dependent on the activation of brain opiatergic pathways since central injections of naloxone (82.5 nmol/rat), a non-selective opioid antagonist, blunt the thirst-inhibiting effect of these metals. One hundred and twenty minutes after the second third ventricle injections, dehydrated animals (14 h overnight) receiving saline + sodium acetate displayed a high water intake (7.90 ñ 0.47 ml/100 g body weight) whereas animals receiving saline + lead acetate drank 3.24 ñ 0.47 ml/100 g body weight. Animals receiving naloxone + lead acetate drank 6.94 ñ 0.60 ml/100 g body weight. Animals receiving saline + saline drank 8.16 ñ 0.66 ml/100 g body weight whilst animals receiving saline + cadmium chloride drank 1.63 ñ 0.37 ml/100 g body weight. Animals receiving naloxone + cadmium chloride drank 8.01 ñ 0.94 ml/100 g body weight. It is suggested that acute third ventricle injections of both lead and cadmium exert their antidipsogenic effect by activating thirst-inhibiting opioid pathways in the brain


Subject(s)
Animals , Male , Rats , Cadmium/antagonists & inhibitors , Cerebral Ventricles/drug effects , Drinking/drug effects , Lead/antagonists & inhibitors , Narcotics/pharmacology , Cadmium/pharmacology , Lead/pharmacology , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Rats, Wistar
13.
Neurobiologia ; 60(4): 149-58, out.-dez. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-250129

ABSTRACT

Revisão atualizada envolvendo os mecanismos de ação dos opióides a nível dos receptores de membrana celular e seus efeitos sobre o sistema de mensageiros intracelulares


Subject(s)
Narcotics/pharmacology , Analgesics, Opioid/pharmacology , Opioid Peptides/pharmacology , Receptors, Opioid, mu
14.
Paciente crit. (Uruguay) ; 10(2/3): 101-12, 1997. tab
Article in Spanish | LILACS | ID: lil-246858

ABSTRACT

El dolor y la agitación son los síntomas más frecuentes que presentan los pacientes internados en una unidad de cuidados intensivos. En el paciente neurocrítico tienen un perfil especial, pues por la afección neurológica de base, no se traducen en la misma forma que en otros pacientes y el tratamiento de los mismos debe ser eficaz pero sin interferir en la evaluación clínica de los mismos. Ambos tienen efectos adversos y efectos beneficiosos y su tratamiento debe contemplar esta situación. El tratamiento de la agitación exige como primer paso terapéutico definir la causa de la misma, y si Ústa es detectable, corregirla. Se insiste en la importancia que tiene el delirio por deprivación delalcohol, drogas o ambas en el paciente neurocrítico, sobre todo en los traumatismos craneocerebrales. Se definen las indicaciones para administrar sedantes en estos pacientes. Se describen los fármacos usualmente utilizados con dicho propósito, señalando vías de administración, dosis, y efectos colaterales. Se resumen los principios básicos para el manejo del paciente excitado que estáß intubado o no. Se señala la alta prevalencia del dolor en los pacientes neurológicos, la forma de detectarlo y la oportunidad de tratarlo. Se hace referencia a los analgésicos habitualmente utilizados para la analgesia del paciente neurocrítico, su forma de administración y sus efectos adversos


Subject(s)
Humans , Psychomotor Agitation/drug therapy , Analgesia , Nervous System Diseases/complications , Pain/drug therapy , Benzodiazepines/pharmacology , Narcotics/pharmacology , Substance Withdrawal Syndrome/therapy
15.
In. Paeile Jacquier, Carlos; Bilbeny L., Norberto. El dolor: aspectos básicos y clínicos. Santiago de Chile, Mediterráneo, 2 ed; 1997. p.60-77, ilus, tab.
Monography in Spanish | LILACS | ID: lil-284916
16.
In. Paeile Jacquier, Carlos; Bilbeny L., Norberto. El dolor: aspectos básicos y clínicos. Santiago de Chile, Mediterráneo, 2 ed; 1997. p.339-48, tab.
Monography in Spanish | LILACS | ID: lil-284928
18.
In. Paeile Jacquier, Carlos; Bilbeny L., Norberto. El dolor: aspectos básicos y clínicos. Santiago de Chile, Mediterráneo, 2 ed; 1997. p.449-54.
Monography in Spanish | LILACS | ID: lil-284934
20.
Rev. Inst. Nac. Enfermedades Respir ; 8(4): 313-8, oct.-dic. 1995. tab
Article in Spanish | LILACS | ID: lil-167582

ABSTRACT

El periodo neonatal comprende las cuatro primeras semanas de vida. Durante este aparente corto periodo se presentan cambios anatómicos y fisiológicos que le permiten al neonato adaptarse a la vida extrauterina. Se hace énfasis en las diferencias que deben estar siempre presentes en la mente del médico para un manejo anestésico exitoso en los pacientes. Asimismo, se hace una revisión de las patologías congénitas que en muchas ocaciones son incompatibles con la vida y se discute el manejo anestésico de cada una de ellas


Subject(s)
Infant, Newborn , Humans , Anesthetics/administration & dosage , Anesthesia , Body Temperature/drug effects , Pyloric Stenosis/surgery , Hernia, Diaphragmatic/surgery , Hernia, Umbilical/surgery , Intubation, Intratracheal , Narcotics/pharmacology , Neonatology , Parasympatholytics/administration & dosage , Infant, Newborn/physiology
SELECTION OF CITATIONS
SEARCH DETAIL